Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

News | Cardiac Imaging

November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...

Home November 03, 2017
Home
The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.
Feature | Dave Fornell

November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home November 03, 2017
Home
Technology | FFR Technologies

November 3, 2017 — Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini ...

Home November 03, 2017
Home
The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation

November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...

Home November 02, 2017
Home
The B. Braun Sequent Please drug-eluting balloon.
Feature | Drug-Eluting Balloons

November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...

Home November 02, 2017
Home
News | Chronic Total Occlusion (CTO)

November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...

Home November 02, 2017
Home
News | Stents Drug Eluting

November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...

Home November 01, 2017
Home
News | Stents Bifurcation

November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...

Home November 01, 2017
Home
News | Heart Valve Technology

November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...

Home November 01, 2017
Home
News | Cath Lab

November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strategy ...

Home November 01, 2017
Home
News | Embolic Protection Devices

October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the ...

Home October 31, 2017
Home
News | Heart Valve Technology

October 31, 2017 — Edwards Lifesciences Corp. announced new data demonstrating substantial economic advantages of the ...

Home October 31, 2017
Home
News | Stents Bioresorbable

October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...

Home October 31, 2017
Home
News | Stents Bioresorbable

October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...

Home October 31, 2017
Home
Subscribe Now